title: Experimental study of antiblastic activity in potentiated antibodies to tumor necrosis factor-alpha.
abstract: In mice with Lewis lung carcinoma and melanoma B-16 administration of potentiated antibodies to tumor necrosis factor-alpha started 1 day after transplantation of a small number of tumor cells (10(6)) produced an antiblastic effect.
authors.affiliation: Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences.
authors.forename: E N
authors.initials: EN
authors.lastname: Amosova
authors.forename: E P
authors.initials: EP
authors.lastname: Zueva
authors.forename: T G
authors.initials: TG
authors.lastname: Razina
authors.forename: A V
authors.initials: AV
authors.lastname: Martyushev
authors.forename: O I
authors.initials: OI
authors.lastname: Epstein
authors.forename: S G
authors.initials: SG
authors.lastname: Krylova
authors.forename: N V
authors.initials: NV
authors.lastname: Shilova
mesh_terms: D000818:Animals; D000906:Antibodies / Q000276:immunology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018827:Carcinoma, Lewis Lung / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy; D051379:Mice; D008810:Mice, Inbred C57BL; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
chemical_list: D000906:Antibodies; D000970:Antineoplastic Agents; D014409:Tumor Necrosis Factor-alpha